Purpose The purpose of this study was to evaluate the outcomes of phacoemulsification in patients with ocular graftversus-host disease (GVHD). Methods The occurrence of cataracts, cataract surgery, and its outcomes were analyzed in the medical records of 229 patients (458 eyes) with ocular GVHD. Outcome measures included pre-and postoperative corrected distance visual acuity (CDVA) and the rate of postoperative complications. Results Of the 458 eyes evaluated, 58 were pseudophakic; from the 400 phakic eyes, 238 (59 %) presented with cataracts and 62 (26 %) underwent cataract surgery. Analysis of postoperative complications and visual outcomes at 1 month was performed in 51 eyes in which detailed surgical and immediate postoperative records were available. Preoperatively, the mean CDVA was 0.67±0.57 LogMAR (Snellen 20/93), improving postoperatively to 0.17 ± 0.18 (Snellen 20/29) at 1 month (P<0.0001), and to 0.13±0.14 (Snellen 20/26) by the final follow-up visit (P<0.0001). Postoperative complications included corneal epithelial defects (8 %), filamentary keratitis (6 %), worsening of corneal epitheliopathy (16 %), posterior capsular opacification (18 %), and cystoid macular edema (4 %). A corrected distance visual acuity of 20/30 or better was achieved in 87 % of the eyes; suboptimal CDVA improvement was attributable to severe ocular surface disease, pre-existing advanced glaucoma, and prior macular surgery. Conclusions Phacoemulsification in patients with chronic ocular GVHD is a safe and efficacious procedure resulting in significant visual improvement. Overall, postoperative adverse events responded well to timely management.
Introduction
Hematopoietic stem cell transplantation (HSCT) is an established treatment for various hematological disorders [1] . Advancements in transplantation techniques have led to an increase in the number of procedures performed annually and have contributed to the long-term survival of these patients [1, 2] . As a result, long-term complications after HSCT are becoming the main factor affecting patients' quality of life [3] . Chronic graft-versus-host disease (GVHD), a condition originating from an immune response of donor T cells against the recipient's tissues, has become a major cause of morbidity and mortality after allogeneic HSCT [4] . Ocular manifestations in patients with chronic GVHD are present in 60-90 % of cases [5] . Ocular GVHD commonly presents with eye discomfort, pain, grittiness, redness, light sensitivity, and blurred vision. Clinical signs include conjunctival hyperemia, corneal epitheliopathy, meibomian gland dysfunction, conjunctival and corneal scarring, and stromal ulceration, which negatively affect vision-related quality of life [4] [5] [6] .
Posterior subcapsular (PSC) cataracts are highly prevalent in patients undergoing HSCT, primarily as a result of irradiation and steroid treatment [7] [8] [9] . Furthermore, cataracts have been reported as a major cause of decreased visual acuity in patients with systemic GVHD [10] . Consequently, a large number of patients are expected to undergo cataract surgery in the setting of ocular GVHD. Ocular surface manifestations of GVHD may affect the outcomes of cataract surgery and the postoperative course in these patients. There is limited information available in the current literature regarding the outcomes of cataract surgery in patients with chronic ocular GVHD [11, 12] . The purpose of this study was to evaluate visual outcomes and postoperative complications of phacoemulsification in patients with chronic ocular GVHD.
Methods
We conducted a retrospective study that involved chart review of 229 patients with chronic ocular GVHD examined at the Cornea Service of the Massachusetts Eye and Ear Infirmary (MEEI) from May 2007 through December 2012. The study was approved by the Institutional Review Board and followed the tenets of the Declaration of Helsinki. Patients were selected according to the National Institutes of Health (NIH) diagnostic criteria for chronic ocular GVHD. These criteria are defined by a distinctive manifestation of systemic GVHD accompanied by 1) new ocular sicca, documented with a bilateral Schirmer test averaging ≤ 5 mm, or 2) new onset of ocular sicca determined by slit-lamp examination with a bilateral Schirmer test averaging 6-10 mm [13] .
We evaluated the presence and types of cataracts in patients with ocular GVHD and the surgical outcomes in those who underwent cataract surgery. Data collected included information regarding patient demographics, slit-lamp and fundus exam results, change between preoperative and postoperative visual acuity, and intraoperative and postoperative findings. The surgical outcomes included corrected distance visual acuity at 1 month and last follow-up visit, as well as intraoperative and postoperative complications. All postoperative ocular surface events occurring within 4 weeks postoperatively were considered related to the surgical procedure.
Statistical analysis
Mean corrected distance visual acuity values were calculated after converting recorded data from Snellen to LogMAR scales. Normality of the data was evaluated using the D'Agostino-Pearson omnibus test. The Wilcoxon signedrank test was used to compare preoperative and postoperative corrected distance visual acuity and corneal fluorescein staining. A two-sided P value of <0.05 was considered statistically significant. We calculated the occurrence of postoperative complications and expressed it as a proportion of total eye interventions.
Results
A total of 458 eyes with a diagnosis of chronic ocular graftversus host disease were included, from which 58 eyes (13 %) were pseudophakic at the initial visit. From the 400 phakic eyes, 162 (40.5 %) had a clear lens, and 238 (59.5 %) presented with one or more types of lens opacities as described in Table 1 . In total, nuclear sclerosis was seen in 158 eyes (39.5 %), posterior subcapsular cataracts in 132 eyes (33 %), and cortical cataracts in 22 eyes (5.5 %). Cataract surgery was performed on 62 eyes, representing 26 % of all eyes diagnosed with cataracts. Posterior subcapsular cataracts were present in all eyes that underwent surgery, either alone (33 eyes) or in combination with nuclear sclerosis or cortical opacity (29 eyes). Analysis of postoperative complications and visual outcomes at 1 month was performed in 51 eyes with detailed surgical and immediate postoperative records. In six patients (11 eyes) who underwent surgery, the surgical procedure was performed by their primary ophthalmologist but the patients were followed at our ocular surface clinic and were included in the visual acuity analyses for the preoperative and final visits.
At the time of cataract surgery, the mean patient age was 50±13 years (range: 22-72). The mean interval of time between HSCT and development of ocular GVHD in patients undergoing cataract surgery was 19±28 months (median: 11, range: 1-159 months). All patients presented clinical features of chronic ocular GVHD, with the exception of one patient, who first presented with acute ocular GVHD but later developed chronic ocular GVHD. Phacoemulsification was performed 42 ± 33 months (median: 32, range: 19-251) after HSCT and 23± 19 months (median: 19, range: 2-91) after the diagnosis of ocular GVHD. The mean duration pf patient follow-up after cataract surgery was 12±13 months (1-50). The primary disorder for which HSCT was performed, conditioning regimens, and extraocular GVHD involvement are shown in Table 2 ; other concurrent pathological conditions in eyes undergoing cataract surgery are shown in Table 3 .
Surgical procedure
In all eyes undergoing cataract surgery, adequate control of ocular surface disease was achieved preoperatively. Preoperative topical and systemic therapy for ocular GVHD and concurrent systemic GVHD are shown in Table 4 . Treatment with topical autologous serum was discontinued during a period from 3 days prior to surgery until 1 week post-surgery, since it is rich in protein and growth factors, and hence may increase the risk of microbial colonization and infection in the setting of intraocular surgery [14, 15] . Scleral contact lenses were removed immediately before intraocular lens calculation in order to ensure an even ocular surface and accurate biometry, and their use was subsequently resumed until the day of surgery. Postoperatively, scleral contact lens wear recommenced after 1 week if the corneal wound was sutured, and after 3 to 4 weeks otherwise. Phacoemulsification through a clear corneal incision with posterior chamber intraocular lens implantation was performed in all eyes. Postoperatively, 1 % topical prednisolone acetate was prescribed for application four times a day, tapered over 4 weeks, and topical fluoroquinolone applied four times a day for 1 week. Patients were examined postoperatively at day 1, week 1, and 1 month after surgery unless otherwise required. After 1 month, the frequency of visits depended on the status of the ocular surface.
Visual outcomes
The mean preoperative CDVA was 0.67 ±0.57 LogMAR (Snellen 20/93), improving to 0.17±0.18 (Snellen 20/29) at 1 month postoperatively (P < 0.0001) and to 0.13 ± 0.14 (Snellen 20/26) at the final follow-up visit (P<0.0001). Table 5 shows visual acuity measurements at 1 month and at the final (4) or prior macular surgery (1), while three eyes had severe dry eye with corneal epitheliopathy, some of which required management with scleral contact lens.
Intraoperative findings
There were no severe intraoperative complications. One eye required limited anterior vitrectomy with intraocular lens implantation in the sulcus due to a posterior capsular tear.
Postoperative findings

Corneal epithelial defects
Corneal epithelial defects ≥ 1 mm were noted in four eyes (8 %): two eyes at postoperative day 2, one eye at day 7, and one eye at day 14. Epithelial defects were located centrally in all eyes, and resolved within 1 week after treatment with lubrication, antibiotic ointment, and bandage contact lens (three eyes).
Filamentary keratitis
Filamentary keratitis was noted in three eyes (6 %), at postoperative days 1 (one eye) and 14 (two eyes).
Corneal punctate keratitis
Worsening of corneal epitheliopathy was noted in eight eyes (16 %), at postoperative weeks 1 (six eyes) and 4 (two eyes). We were not able to compare the pre-and postoperative corneal fluorescein staining in every patient due to a lack of consistent data recorded in the same scheme for all visits (e.g., NEI or Oxford scheme). In 45 % of the cases, the preoperative and postoperative (1 week and 1 month) corneal fluorescein staining values were available in the modified Oxford scheme. In this subgroup of patients, the mean corneal fluorescein staining increased from 1.02±0.77 Oxford units preoperatively to 1.65±1.29 units at 1 week postoperatively (P=0.04), and subsequently decreased to 1.30±1.05 units at 1 month postoperatively (P=0.23, compared to the preoperative score). Of the eight eyes with exacerbated punctate keratitis after surgery, two eyes had been treated preoperatively with autologous serum. After restarting the preoperative topical therapy, including autologous serum, both eyes reached preoperative punctate keratitis levels by 8 weeks. Exacerbation of punctate keratitis after surgery responded to treatment with one or more of the following: preservative-free lubricant eye drops, topical corticosteroids, punctal plugs, resumption of topical autologous serum, and scleral or bandage contact lenses.
Posterior capsular opacification (PCO)
Vision-impairing posterior capsular opacification (PCO) where laser capsulotomy was indicated was present in nine eyes (18 %) and was noted between 1 and 8 months after surgery.
Cystoid macular edema (CME)
Cystoid macular edema was diagnosed when cystic changes were evident either by fundoscopy or by optical coherence tomography, and when visual acuity was≤20/40. CME was noted in the two eyes (4 %) of the same patient at months 5 and 7 postoperatively. Both eyes underwent uneventful phacoemulsification, and were treated with yttrium aluminium garnet (YAG) laser capsulotomy due to PCO 3 months after the surgery. After unsatisfactory visual acuity improvement, a macular comprehensive evaluation revealed the presence of CME. However, fundus examination also revealed retinal microaneurysms and microhemorrhages in both eyes, while fluorescein angiography revealed perifoveal telengiectatic vessels; a diagnosis of radiation retinopathy was made by the MEEI Retina Service. The CME responded to topical nonsteroidal anti-inflammatory treatment only in one eye, but required subtenonian triamcinolone and intravitreal bevacizumab in the fellow eye. At the final follow-up visit, both eyes showed improvement, with visual acuity of 20/25 and 20/30, respectively.
Discussion
In this retrospective study, cataracts were present in 59 % of the eyes of patients with chronic ocular GVHD. Twenty-six percent of these eyes underwent cataract surgery with good visual outcomes, represented by a postoperative corrected distance visual acuity of 20/30 or better in 87 % of the eyes. Of eight eyes (13 %) that did not achieve visual acuity of 20/30, three eyes (5 %) presented severe ocular surface disease, four eyes (6 %) advanced glaucoma, and one eye (2 %) previous macular surgery (Table 3) . We observed nuclear sclerosis in 39.5 % of the eyes with ocular GVHD, which is in concordance with the prevalence of nuclear sclerosis reported in the general population (19 to 51 %), most likely reflecting changes in the lens associated with aging [16, 17] . However, the prevalence of posterior subcapsular cataracts noted in our cohort (33 %) is fivefold greater than that reported in the general population [16, 17] . Our study is consistent with other studies reporting a high prevalence (up to 48 %) of PSC cataracts in patients with systemic GVHD [8, 10] . This can be explained to a large degree by the known association between exposure to radiation and systemic corticosteroids and the development of posterior subcapsular cataracts in patients receiving hematopoietic stem cell transplants [8, [18] [19] [20] . In the present study, 47 % of the eyes diagnosed with PSC cataracts underwent cataract surgery at a mean age of 50 years, a considerably younger age compared to the mean age of individuals undergoing cataract surgery in the general population [21, 22] .
Cataract surgery can induce or aggravate pre-existing dry eye disease [23] . Ocular surface complications such as punctate keratitis, recurrent epithelial defects, filamentary keratitis, and corneal melting have been reported after cataract surgery in patients with dry eye disease, especially those associated with systemic disorders such as Sjögren's syndrome and rheumatoid arthritis [24] [25] [26] . In patients with pre-existing aqueous deficiency and an unstable tear film who undergo cataract surgery, the inflicted insult due to incision (nerve damage), ocular surface exposure, and toxicity from eye drops may cause corneal vulnerability to epithelial breakdown [23, 27] . In our series, the incidence of epithelial defects after cataract surgery was 8 %. Other studies on cataract surgery in patients with dry eyes after bone marrow transplantation have reported epithelial defects in 0-3 % of the eyes [11, 12] , and one study in patients with dry eye secondary to connective tissue disorders and older age reported epithelial defects in 32 % of cases [26] . In the current study, three of the four eyes that developed epithelial defects were being treated with scleral contact lenses and two with topical autologous serum prior to the surgery, which is indicative of severe ocular surface disease. Additionally, cessation of treatment with scleral lenses and topical autologous serum in the early postoperative period might have contributed to the development of epithelial defects. However, all epithelial defects responded satisfactorily to adequate treatment and resolved within 1 week. Based on our observations and other studies, the evidence suggests that the occurrence of postoperative epithelial breakdown is largely influenced by the severity of dry eye disease at the time of surgery. Ocular inflammation triggers mucus production, and adherence of the mucus strands to the compromised epithelium leads to filamentary keratitis, which was noted in 6 % of the cases in the early postoperative period.
We noticed worsening of corneal epitheliopathy in 16 % of eyes in the early postoperative period. The comparison between the pre-and postoperative corneal fluorescein staining scores revealed a statistically significant increase in mean corneal fluorescein staining 1 week after the cataract surgery, which subsequently decreased at 1 month postoperatively, reflecting at this later point no statistically significant difference with the preoperative scores. This pattern is similar to that described in the general population after phacoemulsification [28] .
Vision-impairing PCO that required YAG laser capsulotomy developed in 18 % of the eyes that were operated on, and was noted between 1 and 8 months after surgery. The general incidence of PCO reported within 1 year of cataract surgery varies from 2 to 11 % [29] [30] [31] . A metaanalysis by Schaumberg et al. reported an estimated 11.8 % incidence of PCO within 1 year of surgery and 20.7 % within 3 years [32] . Development of PCO is influenced by several factors, including patient age, type of surgery, materials and design of intraocular lenses, and follow-up period, making it difficult to compare rates of incidence among studies. In the current study, a higher incidence of PCO compared to that reported for the general population is likely related to the high prevalence of PSC cataracts, treatment with systemic corticosteroids, and a younger mean patient age, all of which have been linked to posterior capsular opacification [33] [34] [35] . Interestingly, the 18 % incidence of PCO noted in this study is much lower than the 44 % PCO incidence reported by our group in 2001 in recipients of bone marrow transplants who underwent cataract surgery. The reduction in incidence of PCO may be influenced by advancements in surgical techniques and intraocular lenses, as reported for the general population [11, 36] .
The patient who presented with bilateral cystoid macular edema several months after cataract surgery was ultimately diagnosed with bilateral radiation retinopathy. This patient had a history of standard treatment with fractionated totalbody irradiation as a part of a pre-transplant conditioning regimen, but also received cranial radiation. Penn et al. reported a similar case with bilateral CME in a patient with ocular GVHD after cataract surgery; however, the CME in that patient was noted within 2 months of cataract surgery, and there was no mention of radiation retinopathy [12] . It is unlikely that the occurrence of bilateral CME in this case was related to the cataract surgery, given the delayed appearance after 6 months and the concurrent diagnosis of associated radiation retinopathy. Radiation is well known to inflict damage to the retinal vascular endothelium, resulting in capillary occlusion, microaneurysm formation, and telengiectatic vessels, and ultimately leading to leakage and macular edema [37] . However, it is possible that radiation-induced retinal compromise may predispose to the development of macular edema in the setting of otherwise uncomplicated cataract surgery. Awareness of this potential risk and assessment of the macular condition in previously irradiated patients undergoing cataract surgery (e.g., by optical coherence tomography) may aid in better understanding the patient's ocular condition and in implementing the appropriate procedures to improve the ultimate visual prognosis.
The present study has limitations inherent in its retrospective design, including the variability of postoperative followup within the cohort. It is important to emphasize that it is difficult for the ophthalmologist to follow up patients with ocular GVHD. These patients are usually followed up in oncology or internal medicine departments, and have multiple serious systemic conditions that frequently result in hospitalization or mortality, thus leading to variability in follow-up for an eye clinic. However, we believe that despite these limitations, the evidence from this large cohort provides valuable clinical data regarding the visual potential and expected complications of cataract surgery in patients with ocular surface disease secondary to GVHD. To overcome the most common limitations we face with these patients, we propose the creation of a multicentric registry that facilitates accessibility to accurate and continuously updated data from large cohorts, hence improving our understanding of ocular GVHD, its natural history, and the impact of cataract surgery and other interventions.
In summary, visual outcomes of phacoemulsification in patients with chronic ocular graft-versus-host disease were excellent, resulting in visual acuity of 20/30 or better in 95 % of eyes, with no concurrent pathological condition other than GVHD. No serious adverse events occurred, and ocular surface complications responded well to appropriate management. Awareness of concurrent comorbidities, such as severe ocular surface impairment or posterior segment conditions, may help to identify cases with a more reserved visual prognosis. Here, we show that optimal preoperative stabilization of the ocular surface and timely identification and management o f c o m p l i c a t i o n s h a v e p r o v e n t h e e f f i c a c y o f phacoemulsification for the treatment of patients with ocular graft-versus-host disease.
